"Stepped back, took a look, saw a pimple on an elephants arse....just saying."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is huge news guys, lots going on here. eom
I love this part: announced today that it is expanding its multimillion dollar national advertising campaign
XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
http://ih.advfn.com/p.php?pid=nmona&article=41164873&symbol=USBB:NPHC&cb=1263909878
XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it is expanding its multimillion dollar national advertising campaign to include direct response mailings, television commercials, national sponsorships and additional print advertising to support the rapidly growing network of retailers carrying Cobroxin, an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain
“We introduced Cobroxin, through e-commerce websites, during the last quarter of 2009. This quarter, we are pleased to report that the product has been reviewed and accepted by 40% of the 105,000 retail stores selling healthcare products across the United States, as reported by Chain Drug Review magazine,” said Frank Rizzo, President and CEO of XenaCare Holdings. “We anticipate the average retailer will place an opening order of $80 per store location. With analgesic products producing up to 21 inventory turnovers per year, the upside potential is dramatic and very exciting for Cobroxin,” he concluded
In addition to its current print advertising campaign, XenaCare Holdings has purchased advertising in several men’s, women’s and specialty magazines. These advertisements are scheduled to debut in February and are projected to generate approximately 108 million reader impressions over the next 3 months. Cobroxin will also be featured in several printed retail catalogs, reaching approximately 18 million households throughout the United States
Recently, the Company became a National Proud Sponsor of the Arthritis Foundation. This sponsorship allows XenaCare Holdings to use the Foundation’s logo on packaging, websites, print advertisements, retail catalogs and when sending out direct mailers to 100,000 Arthritis Foundation members. XenaCare Holdings plans to continue strengthening its relationship with the Arthritis Foundation and supporting the Foundation’s mission throughout 2010
In October, the Company announced that it would be advertising in the official annual publication of NASCAR, which reaches approximately 8,000,000 attendees, as well as the NFL Alumni Guide Program and Yearbook. The Company recently expanded this targeted outreach to include advertising in the upcoming 2010 Super Bowl XLIV program guide and the 2010 NBA All-Star Game program guide
Cobroxin will also be featured in direct response advertising with 60 second spots beginning in late January 2010
Finally, XenaCare Holdings has begun production for a series of television commercials scheduled to air in April. Additional details regarding these commercials will be released in the near-term
Cobroxin is currently available to independent pharmacy owners through the Chain Drug Marketing Association (CDMA), one of the largest pharmacy organizations representing more than 6,000 retail outlets throughout 32 states. Additionally, Cobroxin will be sold through most mass market retailers, including major drugstore chains and supermarkets, as well as online at Cobroxin.com, Amazon.com, Overstock.com and Drugstore.com
Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis
Additional benefits to Cobroxin include:
All Natural
Non-Addictive
Non-Narcotic
Non-Opiate
More Potent than Morphine
Long Lasting
XenaCare Holdings was granted the exclusive license by Nutra Pharma Corporation (OTCBB:NPHC) to market and dist
XCHO XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
http://ih.advfn.com/p.php?pid=nmona&article=41164873&symbol=USBB:NPHC&cb=1263909878
XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it is expanding its multimillion dollar national advertising campaign to include direct response mailings, television commercials, national sponsorships and additional print advertising to support the rapidly growing network of retailers carrying Cobroxin, an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain
“We introduced Cobroxin, through e-commerce websites, during the last quarter of 2009. This quarter, we are pleased to report that the product has been reviewed and accepted by 40% of the 105,000 retail stores selling healthcare products across the United States, as reported by Chain Drug Review magazine,” said Frank Rizzo, President and CEO of XenaCare Holdings. “We anticipate the average retailer will place an opening order of $80 per store location. With analgesic products producing up to 21 inventory turnovers per year, the upside potential is dramatic and very exciting for Cobroxin,” he concluded
In addition to its current print advertising campaign, XenaCare Holdings has purchased advertising in several men’s, women’s and specialty magazines. These advertisements are scheduled to debut in February and are projected to generate approximately 108 million reader impressions over the next 3 months. Cobroxin will also be featured in several printed retail catalogs, reaching approximately 18 million households throughout the United States
Recently, the Company became a National Proud Sponsor of the Arthritis Foundation. This sponsorship allows XenaCare Holdings to use the Foundation’s logo on packaging, websites, print advertisements, retail catalogs and when sending out direct mailers to 100,000 Arthritis Foundation members. XenaCare Holdings plans to continue strengthening its relationship with the Arthritis Foundation and supporting the Foundation’s mission throughout 2010
In October, the Company announced that it would be advertising in the official annual publication of NASCAR, which reaches approximately 8,000,000 attendees, as well as the NFL Alumni Guide Program and Yearbook. The Company recently expanded this targeted outreach to include advertising in the upcoming 2010 Super Bowl XLIV program guide and the 2010 NBA All-Star Game program guide
Cobroxin will also be featured in direct response advertising with 60 second spots beginning in late January 2010
Finally, XenaCare Holdings has begun production for a series of television commercials scheduled to air in April. Additional details regarding these commercials will be released in the near-term
Cobroxin is currently available to independent pharmacy owners through the Chain Drug Marketing Association (CDMA), one of the largest pharmacy organizations representing more than 6,000 retail outlets throughout 32 states. Additionally, Cobroxin will be sold through most mass market retailers, including major drugstore chains and supermarkets, as well as online at Cobroxin.com, Amazon.com, Overstock.com and Drugstore.com
Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis
Additional benefits to Cobroxin include:
All Natural
Non-Addictive
Non-Narcotic
Non-Opiate
More Potent than Morphine
Long Lasting
XenaCare Holdings was granted the exclusive license by Nutra Pharma Corporation (OTCBB:NPHC) to market and dist
XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
http://ih.advfn.com/p.php?pid=nmona&article=41164873&symbol=USBB:NPHC&cb=1263909878
XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin...
XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it is expanding its multimillion dollar national advertising campaign to include direct response mailings, television commercials, national sponsorships and additional print advertising to support the rapidly growing network of retailers carrying Cobroxin, an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain
“We introduced Cobroxin, through e-commerce websites, during the last quarter of 2009. This quarter, we are pleased to report that the product has been reviewed and accepted by 40% of the 105,000 retail stores selling healthcare products across the United States, as reported by Chain Drug Review magazine,” said Frank Rizzo, President and CEO of XenaCare Holdings. “We anticipate the average retailer will place an opening order of $80 per store location. With analgesic products producing up to 21 inventory turnovers per year, the upside potential is dramatic and very exciting for Cobroxin,” he concluded
In addition to its current print advertising campaign, XenaCare Holdings has purchased advertising in several men’s, women’s and specialty magazines. These advertisements are scheduled to debut in February and are projected to generate approximately 108 million reader impressions over the next 3 months. Cobroxin will also be featured in several printed retail catalogs, reaching approximately 18 million households throughout the United States
Recently, the Company became a National Proud Sponsor of the Arthritis Foundation. This sponsorship allows XenaCare Holdings to use the Foundation’s logo on packaging, websites, print advertisements, retail catalogs and when sending out direct mailers to 100,000 Arthritis Foundation members. XenaCare Holdings plans to continue strengthening its relationship with the Arthritis Foundation and supporting the Foundation’s mission throughout 2010
In October, the Company announced that it would be advertising in the official annual publication of NASCAR, which reaches approximately 8,000,000 attendees, as well as the NFL Alumni Guide Program and Yearbook. The Company recently expanded this targeted outreach to include advertising in the upcoming 2010 Super Bowl XLIV program guide and the 2010 NBA All-Star Game program guide
Cobroxin will also be featured in direct response advertising with 60 second spots beginning in late January 2010
Finally, XenaCare Holdings has begun production for a series of television commercials scheduled to air in April. Additional details regarding these commercials will be released in the near-term
Cobroxin is currently available to independent pharmacy owners through the Chain Drug Marketing Association (CDMA), one of the largest pharmacy organizations representing more than 6,000 retail outlets throughout 32 states. Additionally, Cobroxin will be sold through most mass market retailers, including major drugstore chains and supermarkets, as well as online at Cobroxin.com, Amazon.com, Overstock.com and Drugstore.com
Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis
Additional benefits to Cobroxin include:
All Natural
Non-Addictive
Non-Narcotic
Non-Opiate
More Potent than Morphine
Long Lasting
XenaCare Holdings was granted the exclusive license by Nutra Pharma Corporation (OTCBB:NPHC) to market and dist
Thanks for the heads-up geodan. I think we are in for some exciting times ahead.
I feel everyone is just lurking here, I am sure they are checking XCHO out like a hawk.
Seems like a very professional outfit and you have to have a net worth of one million dollars to join the club. http://www.accreditedmembers.com/
Having heard Rik speak on a few webinars I think he has all the capabilities of blowing them away. By early February hopefully at these conferences he can back up NPHC future plans with some initial sales figures and some forward visibility.
Did anyone els notice the 27% swing Friday on no news? A pretty sweet move I would say!
GLTY mate. This .095 is getting old, lets see what the week brings. Some nice volume at the close on Friday.
Since I started my DD and took my first position two months ago there has been no BS from the CEO of this company. To date has produced the goods, been honest and done what is best for the shareholders. His dedication speaks volumes to me.
I have never communicated with Ken, so far there has been no reason to. Time will tell.
Gold gains on dollar weakness, copper, oil also rises http://www.commodityonline.com/futures-trading/technical/Gold-gains-on-dollar-weakness-copper-oil-also-rises-14018.html
LOL, what's up mate?!
Birdmanbob4, remember this post ? http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45097047 And this one. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45102590
This is how small money becomes bigger money.
01/04/2010 Buy 388,888.0000 KATX KAT EXPLORATION INC $0.01800 -$7,008.93 $8.95
Two weeks later this is now $21 388.84. In two weeks time it will probably be $58 333.20, etc etc. No kidding, just my personal belief and target. And these shares are all free too, so there is no pressure to sell them
Most people do not understand all the intricacies of gold including me even though I have been studying it for twenty five years.
GL to everyone tomorrow!
What I meant is that as long as you have cash that you can wire into your trading account to "cover" that trade before the settlement day you can still do it.
And then you can still sell as long as you have cash on hand somewhere else to settle that trade. Been in that situation before. eom
I was just wondering if any one else saw that there really is no gap. Well spotted mate!
I am going to go with your last JMO sentence! It will be a frenzy this coming week with the barn burning and the peddle to the metal all maxed out.
Ha! Up 15% on the bounce and not a peep from the board. This is called "bear exhaustion". This is where I have made most of my money in the past, buying up when price shows doom and gloom. eom
I see no real resistance ahead here, so .16 in a few weeks with the right news not impossible at all.
btw called this move on 11 Jan. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45348072
Sometimes you just get lucky.
.50 per share in a week or two?Banjo, this target is not impossible, not common but not impossible either. I have been in a gold stock before that went from .02 to .74 in a few weeks, this happened twelve years ago, a couple of years before the begining of the gold bull. My story can be verified through Jim Bishop an ihub member with 750 people marks. He saw it too, and was trading it in those crazy early board days. http://investorshub.advfn.com/boards/profile.asp?user=92
Yes, I have been trading gold stocks for may years and this is one of the very best I have ever seen. When you see what the fever of yellow does you could be amazed at the power it will move at. Look at the powerful move it has made these past few months.
So, your .50 target is not a pipe dream, I have seen it happen.
Nothing wrong with a little Saturday evening pump, hey.
ErOck, thanks again for all your hard work this week. I had some beverages for you yesterday evening and have been in a sorry state all day. What a fantastic week! Much more to come.
NPHC new HOD +20%. Updates coming next week. eom
Don't want a spinning top either. eom
Don't want a spinning top either. eom
Who wants to be out of this for three whole days? Not me. I say last 15 minutes we charge to .059 eom
NPHC bouncing off double bottom, new HOD up 16%. .335x.35
17.40 AMTD broken neck. eom
Fisker Automotive Secures Additional Funding for Plug-in Hybridshttp://ih.advfn.com/p.php?pid=nmona&article=41132320&symbol=NASDAQ:QTWW&cb=1263581502
Thanks for the update mate!
I am going to stick my head out here and say that the double bottom is in. I just hope I am correct.
Kat Exploration Secures up to $5 Million Funding With 50 Million Restricted Shares and Retires REG-D 504
Congratulations mate!
What the heck is going on with level II or is it just me.....????????
It is 2a.m. on the East Coast, I think that I am going to have a mega headache when I wake up, this was a big day for me, maybe if I drink a ton of water I will not be hanging over, what the hell ... good night...eom
Closed right at high of day.!!!!
Guess I am just about in the green again, that did not take long!
EVRN Edit 52%
EVRN new HOD .0075 up27%
Watch them try take it down here, same as yesterday. I do not think they will get it down this time around.
Wow, $3.76 trade for 100 shares just went through. Is there any truth to those MM messages?